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Diamond Blackfan anemia (DBA) is an inherited syndrome usually presenting with 
severe macrocytic anemia in infancy. We describe a toddler with mild normocytic 
anemia that did not require treatment, who was diagnosed with DBA. This case 
demonstrates the wide clinical spectrum of DBA, mandating high clinical suspicion of 
the disease.  
Introduction  
Diamond Blackfan anemia (DBA) is a disorder of ribosomal production, which is 
characterized by reduced erythroid precursors in the bone marrow and macrocytic 
anemia.  Erythrocyte adenosine deaminase (ADA) and hemoglobin F levels are usually 
elevated1,2. Extra hematopoietic manifestations include growth retardation, thumb 
abnormalities, facial dysmorphism and congenital heart defects. Most patients are 
diagnosed before the age of 1 year. However, recently there has been increasing 
awareness of atypical milder presentation, termed “non-classical”1. We describe a 
toddler with DBA who presented with mild normocytic anemia and neutropenia, in which 
the only clue for the diagnosis was a triphalengeal thumb. This case emphasizes the 
need to consider DBA in the differential diagnosis in patients with non-classical 
presentation.  
Case report 
A 15-month old female patient was referred to our hematology clinic for evaluation of 
anemia. The patient was born at term and her birth weight was 2200 grams. Family 
history was unremarkable. She was diagnosed with a single umbilical artery and a right 
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triphalangeal thumb. Echocardiography at the age of 4 months demonstrated a small 
patent foramen ovale. At the age of 8 months the patient underwent correction of her 
thumb abnormality.  
At the age of 6 months her hemoglobin level was 8.6g/dL with a mean corpuscular 
volume (MCV) of 86.4 fl. Ferritin, serum iron, vitamin B12 levels and thyroid function 
tests were normal. Osmotic fragility test was also normal. Hemoglobin electrophoresis 
at the age of 15 months showed hemoglobin F of 2.4% (normal < 1%) and hemoglobin 
A2 of 2.7% (normal < 3.5%).  
On her first visit in our hematology clinic, the physical examination revealed a systolic 
murmur of 2-3/6, and a surgical scar on the right thumb. Her complete blood count 
(CBC) disclosed an hemoglobin of 10.9g/dL, MCV-81fL, reticulocyte count-1%, white 
blood cell count- 6830/uL, absolute neutrophil count-900/uL, and platelets count of 
344,000/uL. Peripheral blood smear revealed a normal morphology of all lineages. Bone 
marrow aspiration showed normal cellularity, normal maturation of the myeloid cells, 
and mildly decreased erythroid precursors with a Myeloid:Erythroid ratio of 5:1 (Figure 
1). The patient underwent a workup for suspected bone marrow failure that suggested 
included normal telomere length and chromosomal breakage tests. Due to mild 
neutropenia, the patient underwent a workup for cyclic neutropenia that was excluded 
by repeat serial blood counts. Genetic testing was normal for SBDS and ELANE. 
During her follow up, failure to thrive and mild hypotonia were noted. Hemoglobin levels 
were between 9.9-11.4g/dL (except for a single test of 9.2 during an acute illness), with 
MCV levels between 79.6-84.3fl. Neutrophil counts normalized.  The patient never 
required blood transfusions.   
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Eventually, targeted next generation high throughput sequencing was performed. This 
method involves enrichment of a DNA sample for a pre-determined group of genes, 
followed by high throughput sequencing3. It enables a rapid sequencing of all relevant 
genes with a deep coverage4.  This method revealed the change c.527 (+1) G>A (IVS 
5+1) in the RPL5 gene (OMIM 603634) in the patient, and not in family members. 
Sanger sequencing confirmed the splice site mutation that has not been previously 
described. It disrupts the splice donor consensus sequence, and is predicted to be 
deleterious for splicing. The erythrocyte ADA level was 4.5 U/gr of hemoglobin (normal 
value 0.8-1.2U/gr). Ribosomal RNA analyses were also performed. A 32S rRNA species 
(a precursor of the 28S rRNA) was evident (Fig. 2).  Accumulation of tThis rRNA 
precursor specie can be found inis characteristic of patients with abnormalities in the 
large ribosomal subunit5. Thus, the ADA levels and rRNA analysis confirmed the 
pathogenicity of the splice site mutation in RPL5. 
Methods 
Blood samples were collected from the patient and her family members after informed 
consent was obtained. Genomic DNA was isolated from white blood cells using a DNA 
isolation kit for mammalian blood (Roche Diagnostics, Mannheim, Germany), according 
to the manufacturer’s instructions. Sanger sequencing was performed as described6. 
Targeted gene enrichment, sequencing and analysis were performed as previously 
described3. Ribosomal RNA species were evaluated as previously reported5. 
Discussion 
The classical presentation of DBA includes severe macrocytic anemia that is diagnosed 
before the age of 1 year, no other significant cytopenias, paucity of the erythroid 
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precursors in the bone marrow and congenital anomalies. We describe a patient, born 
small for gestational age, with mild normocytic anemia and transient neutropenia who 
had a few congenital anomalies: a single umbilical artery, patent foramen ovale, and a 
triphalengeal thumb. Albeit the atypical clinical presentation, targeted next generation 
sequencing revealed a mutation in the RPL5 gene. Elevated levels of ADA and an 
abnormal ribosomal RNA analysis confirmed the diagnosis of DBA.  
The case emphasizes the growing evidence of non-classial presentation of DBA. In this 
case, the main clue for the diagnosis of DBA was the thumb abnormality.  Triphalangeal 
thumb may occur as an isolated congenital anomaly, in association with other hand 
abnormalities or as a part of a syndrome7. Thumb abnormalities are found in 9-19% of 
patients with DBA1. However, the very mild anemia and the lack of macrocytosis did not 
support reduced suspicion for the diagnosis of DBA and led to a delay in the 
identification of the syndrome in this patient.  
Previous reports include a few patients with DBA whothat had a late onset anemia or a 
relatively mild clinical course. Farruggia et al. describe a patient with RPL5 mutation 
whothat was anemic from infancy but became transfusion-dependent at the age of 12 
years8.  An adult onset of anemia was described in a patient with congenital thumb 
abnormalities and a genetic diagnosis of DBA9. A mother of two DBA patients had 
macrocytosis with no anemia, although carrying the same mutation as her affected 
children10. In a number of cohorts, a few patients were diagnosed at an age older than 
12 months or with a mild anemia that required no therapy11,12,13,14.  
The case we describe, along with previously published cases, emphasize the wide 
clinical variability of DBA and the need to maintain high clinical suspicion of the disorder 
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in patients with thumb abnormalities, even in the presence of mild anemia and only a 
moderatte reduction of red cell precursors in the marrow. Incorporation of the targeted 
next generation sequencing method will not only facilitate an accurate and rapid 
diagnosis of patients with DBA, but may also broaden our understanding of the clinical 
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Figure 1. Bone marrow aspiration of the patient. Left – a representative field. A scale 
bar is located in the right lower corner. Right – a higher magnification of the marked 
field.  Bone marrow aspiration smears (X 50) were stained with Hematek (Siemens) and 
photos were taken with a light microscope (BX51, Olympus). 
 
Figure 2. Ribosomal rRNA electropherogram confirms the pathogenicity of the mutation.  
Total RNA of peripheral blood mononuclear cells of the patient (left panel) compared 
with a healthy control (right panel). A 32S rRNA specie (black arrow) is evident in the 
patient’s sample.  
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